Research Programs

At Dr. Hany Akeel Institute and the Iraqi Medical Research Center, we are committed to advancing scientific knowledge through innovative medical and pharmaceutical research programs. Our research initiatives focus on critical areas that impact healthcare, drug development, and disease management.

1. Pharmacological Research & Drug Development

Our team explores the pharmacodynamics, pharmacokinetics, and clinical applications of new and existing drugs. We focus on:
Drug discovery and synthesis for novel therapeutic agents.
Bioavailability and drug delivery systems for improved patient outcomes.
Toxicology studies to assess drug safety and side effects.

2. Cancer Research & Oncology Studies

We are dedicated to finding new treatment strategies for various types of cancer by:
✔ Investigating targeted therapies and chemotherapy resistance mechanisms.
✔ Studying natural compounds with anticancer properties.
✔ Conducting docking studies for potential anticancer drug candidates.

3. Molecular Genetics & Personalized Medicine

Our research explores genetic markers, molecular biology, and gene therapy to develop personalized treatments. Areas of focus include:
Pharmacogenomics – Understanding how genes affect drug response.
Genetic mutations linked to chronic diseases and cancer.
Gene-editing technologies and regenerative medicine.

4. Infectious Diseases & Antibiotic Resistance

Our institute studies infectious diseases and emerging pathogens, focusing on:
Bacterial resistance mechanisms and alternative antimicrobial strategies.
Viral infections and vaccine development.
Epidemiological research on infectious disease outbreaks.

5. Herbal Medicine & Natural Product Research

We conduct studies on medicinal plants and natural products with therapeutic potential. Key areas include:
Screening plant-based compounds for antibacterial and anticancer properties.
Isolation and structural characterization of bioactive molecules.
Combining traditional herbal medicine with modern pharmacology.

6. Neuropharmacology & Brain Health

Our institute is investigating the effects of pharmaceuticals on brain function, cognition, and neurological disorders, including:
Seizure research and the impact of ECT on neurocognitive function.
Neuroprotective agents and treatments for Alzheimer’s and Parkinson’s disease.
The role of neurotransmitters in psychiatric and neurological disorders.

7. Clinical Trials & Evidence-Based Medicine

We collaborate with hospitals and medical institutions to conduct clinical trials and real-world studies in:
Comparing drug efficacy and safety in various patient populations.
Developing clinical guidelines for disease management.
Investigating new treatment protocols and medical interventions.

Collaborations & Partnerships

We partner with universities, pharmaceutical companies, and global research institutions to enhance the impact of our research. Our goal is to bridge the gap between laboratory findings and real-world medical applications to improve patient care.

If you are interested in collaborating or joining our research programs, please contact us.